Matrix Laboratories Limited, a unit of US-based drugmaker Mylan Inc, has decided to amend its employee stock option plans (ESOP) and set up an ESOP Trust for which it intends to allot 1.83 million equity shares of the company.
The Hyderabad-based company informed stock exchanges on Tuesday that it has convened an extraordinary general meeting on May 30 to seek shareholders’ approval in this regard.
Mylan currently holds 71.16 percent stake in Matrix through MP Laboratories (Mauritius) Ltd, while company's founder N Prasad’s holding is 4.97 per cent.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app